In the absence of FLT3 ITD, Nucleophosmin 1 (NPM1) mutations generally confer a favourable prognosis and NPM1-mutated AML cases do not undergo allogenic transplantation in first complete remission (CR1). The gene discussed is FLT3; the disease is acute myeloid leukemia.